Imagen Technologies is a healthcare technology company that combines AI-powered software with on-site imaging services to support diagnostic imaging for provider organisations across the United States. The company operates in 23 states and has served 3.5 million patients to date.
At the core of Imagen's offering is an end-to-end diagnostic imaging platform built on FDA-cleared AI algorithms, covering modalities that include mammography, fundoscopy, and X-ray. Rather than providing software alone, the company also supplies imaging equipment, clinical workflows, and on-site implementation - enabling healthcare providers to bring diagnostic imaging directly into their facilities. Timely reporting is a stated priority, with the platform designed to reduce turnaround times for results.
Clinical interpretation is delivered by a network of more than 95 board-certified, fellowship-trained specialists who work alongside ordering physicians. This model is positioned as a genuine clinical partnership rather than a remote reading service - specialists engage directly with ordering clinicians to support diagnostic quality. The company serves a range of provider settings, including primary care, women's health, and ophthalmology.
Imagen's stated goals centre on three areas: improving the quality of diagnostic imaging, reducing the cost of delivering it, and expanding patient access - particularly in settings where specialist imaging has historically been unavailable on-site.